Triple-Decker Hexaazamacrocyclic Lanthanide(III) Complexes: Structure, Magnetic Properties, and Temperature-Dependent Luminescence.

The reaction of fluoride anions with mononuclear rare-earth(III) complexes of the hexaazamacrocycle derived from 2,6-diformylpyridine and ethylenediamine affords trinuclear coordination compounds . The X-ray crystal structures of these complexes show triplex cationic complexes where the three roughly parallel macrocyclic lanthanide(III) units are linked by bis-μ-F bridges. The detailed analysis of the photophysical properties of the and complexes reveals different temperature dependence of luminescence intensity and luminescence decay time of the Eu(III) and Tb(III) derivatives.

Scoring donor lungs for graft failure risk: The Lung Donor Risk Index (LDRI).

Lung transplantation lags behind other solid organ transplants in donor lung utilization due, in part, to uncertainty regarding donor quality. We sought to develop an easy-to-use donor risk metric that, unlike existing metrics, accounts for a rich set of donor factors. Our study population consisted of n = 26 549 adult lung transplant recipients abstracted from the United Network for Organ Sharing Standard Transplant Analysis and Research file.

Solid state structures and solution behaviour of tetranuclear lanthanide(III) carbonate-bridged coordination compounds of chiral 3 + 3 amine macrocycle.

The linking of two dinuclear macrocyclic units of large triphenolic hexaazamine by two carbonate anions results in the formation of dimeric tetranuclear Sm(III), Eu(III) and Gd(III) complexes. These complexes were initially obtained serendipitously by fixation of atmospheric carbon dioxide and subsequently obtained in a rational way by the application of carbonate salts. The X-ray crystal structures of these isomorphic complexes show highly folded conformation of the macrocycle.

Transplanting candidates with stacked risks negatively affects outcomes.

Background: Lung transplant (LT) centers are increasingly evaluating patients with multiple risk factors for adverse outcomes. The effects of these stacked risks remains unclear. Our aim was to determine the relationship between the number of comorbidities and post-transplant outcomes.